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Abstract 22 
The mechanism underlying Legionella aerosolization and entry into the respiratory tract remains 23 
poorly documented. In previous studies, we characterized the aerodynamic behaviour of 24 
Legionella aerosols and assessed their regional deposition within the respiratory tract using a 25 
human-like anatomical model. The aim of this study was to assess whether this experimental 26 
setup could mimic the exposure to bioaerosols generated by showers. To achieve this objective 27 
we performed experiments to measure the mass median aerodynamic diameter (MMAD) as well 28 
as the emitted dose and the physiological state of the airborne bacteria generated by a shower 29 
and two nebulizers (vibrating-mesh and jet nebulizers). The MMADs of the dispersed bioaerosols 30 
were characterized using a 12-stage cascade low-pressure impactor. The amount of dispersed 31 
airborne bacteria from a shower was quantified using a Coriolis® Delta air sampler and 32 
compared to the airborne bacteria reaching the thoracic region in the experimental setup. The 33 
physiological state and concentration of airborne Legionella were assessed by qPCR for total 34 
cells, culture for viable and cultivable Legionella (VC), and flow cytometry for viable but non-35 
cultivable Legionella (VBNC). In summary, the experimental setup developed appears to mimic 36 
the bioaerosol emission of a shower in terms of aerodynamic size distribution. Compared to the 37 
specific case of a shower used as a reference in this study, the experimental setup developed 38 
underestimates by 2 times (when the jet nebulizer is used) or overestimates by 43 times (when 39 
the vibrating-mesh nebulizer is used) the total emitted dose of airborne bacteria. To our 40 
knowledge, this report is the first showing that an experimental model mimics so closely an 41 
exposure to Legionella aerosols produced by showers to assess human lung deposition and 42 
infection in well-controlled and safe conditions. 43 
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 47 
Introduction 48 
Members of the genus Legionella (Gram negative bacilli) are ubiquitous in natural and 49 
anthropogenic aquatic ecosystems. These bacteria are responsible for severe pneumonia, which 50 
may be fatal in 30% of cases when considering nosocomial infections. L. pneumophila is, by far, 51 
the most frequent species associated with Legionnaires’ disease (LD). Legionella is now the 52 
number one cause of reported waterborne disease in the United States. The latest 53 
epidemiological data showed an increase in LD worldwide (Centers for Disease Control and 54 
Prevention, 2018; InVS, 2018) with the identification of new sources of contamination by 55 
Legionella aerosol dispersion (i.e., car washing stations (Baldovin et al., 2018), street cleaning 56 
trucks (Valero et al., 2017), aerosols from biologic wastewater treatment plants (Loenenbach et 57 
al., 2018), reclaimed water used for spray irrigation (Pepper and Gerba, 2018), etc.). To assess 58 
the risk of infection of LD, researchers have used the quantitative microbial risk assessment 59 
(QMRA) method to provide models for aerosol dispersion (Thomas W. Armstrong and Haas, 60 
2007; T. W. Armstrong and Haas, 2007; Buse et al., 2012; Hamilton and Haas, 2016; Schoen and 61 
Ashbolt, 2011). However, these risk models are only based (i) on the fluidic characteristics of 62 
water systems that could generate bioaerosols and (ii) on the infectious doses extrapolated to 63 
humans from animal experiments using inhalation, intraperitoneal injections or tracheal 64 
instillation for infection of the animal model. 65 
In previous works, we used a medical nebulization device to generate Legionella aerosols. Thus, 66 
we extensively characterized the bioaerosols produced by a vibrating-mesh nebulizer in terms of 67 
aerodynamic features and airborne Legionella emitted dose (Allegra et al. 2016). We also 68 
experimentally assessed the deposition of these bacteria in the pulmonary region using a 3D 69 
replica of the upper airways (Pourchez et al., 2017) and using an ex vivo ventilated porcine lung 70 
as an innovative human-like respiratory model (Perinel et al., 2018). We showed that the 71 
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developed experimental setup can be used to mimic bacterial inhalation by an anatomical model 72 
of the respiratory tract to assess the Legionella dose reaching the thoracic region for a given 73 
bioaerosol source. Therefore, an interesting further step would consist of demonstrating that 74 
nebulizers can be used to satisfactorily mimic bioaerosol exposure during showering events. 75 
Indeed, if cooling towers are the most significant sources of Legionella outbreaks at a 76 
community level, spa pools and showers from public facilities are the most significant sources of 77 
Legionella nosocomial outbreaks (K. A. Hamilton et al., 2018). 78 
For this purpose, we compared (in terms of aerodynamic size distribution and bacteria 79 
concentration) two different technologies of bioaerosol generation: a vibrating-mesh 80 
nebulization system and a jet nebulizer. The jet nebulizer has been in continuous development 81 
since medicinal aerosol delivery started in the 19th century. Today, the majority of jet nebulizers 82 
are inexpensive devices operated via compressed gas. The gas passes through a small aperture in 83 
the nebulizer to collect and atomize the liquid. The aerosol generated by atomization contains 84 
large and small droplets and is driven to a baffle. Large droplets are impacted by the baffle, while 85 
small droplets are transported out of the nebulizer. In contrast, the vibrating-mesh nebulization 86 
system is a recent technology for aerosol generation using an annular piezo element to produce 87 
mesh vibration to push the liquid through the mesh. Holes in the mesh have a conical structure, 88 
with the largest cross-section of the cone in contact with the liquid. The mesh deforms into the 89 
liquid side, thus pumping and loading the holes with liquid. This deformation on the other side of 90 
the liquid-drug reservoir ejects droplets through the holes. We hypothesize that with these two 91 
technologies, our experimental setup will be able to reproduce many different shower-like 92 
systems on the market place. 93 
For adaptation of our previous model to showering facilities, the original replica of the human 94 
upper airways (El Merhie et al., 2015; Leclerc et al., 2014) was placed in an experimental sealed 95 
enclosure mimicking a shower cubicle and connected to a filter mimicking the thoracic region 96 
5 
(Perinel et al., 2018; Pourchez et al., 2017). A respiratory pump was used to fit the breathing 97 
parameters corresponding to adult male physiology at rest: breathing rate of 15 breaths per 98 
minute and tidal volume of 500 mL (Gradon and Marijnissen, 2003; NF EN 13544-1, 2002). The 99 
results obtained using this experimental setup were compared with the MMAD and the emitted 100 
dose of bioaerosols collected by the Coriolis® Delta air sampler  in the lab’s shower that is 101 
routinely used by the staff. The lab shower will be our reference in this work and hereafter 102 
referred to the “real” shower. 103 
 104 
Materials and methods 105 
Description of the “real” shower experiments used as a reference 106 
The shower analysed in this study is located on the ground floor of the building of the Center for 107 
Health Engineering of Mines Saint-Etienne (CIS, Saint-Etienne, France). This shower is regularly 108 
used by the academic staff and postgraduate students at lunchtime after sporting activities. 109 
Three independent experiments were carried out. The concentration of bacteria in the water 110 
network was determined by sampling 1 litre of water from the first flow and 1 litre during a 111 
thirty-minute showering event respectively at 10, 20 and 30 minutes. The quantity of bioaerosols 112 
dispersed during 10, 20 and 30 minutes was measured by the Coriolis® Delta air sampler (Bertin 113 
Instruments, France) at a flow rate of 300 L.min-1 in a Coriolis collection tube containing 5 mL of 114 
physiological sterile water. The water network samples (1 L) and the Coriolis® Delta collections (5 115 
mL) were concentrated on a polycarbonate membrane by filtration. DNA from each 116 
polycarbonate membrane was extracted with the Power Water DNA extraction kit (MoBio). The 117 
total number of bacteria (in the water network and in bioaerosols) was quantified by qPCR 118 
targeting the 16S RNA gene (see qPCR section). 119 
 120 
Description of the experimental setup to generate bioaerosol and to assess lung deposition 121 
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A previously validated and original respiratory model was used in this study (Pourchez et al., 122 
2017). The setup was composed of a human 3D replica corresponding to the entire nasal cavities 123 
(nasal fossae and frontal, ethmoid and maxillary sinuses) (El Merhie et al., 2015; Le Guellec et al., 124 
2014). This replica was manufactured in transparent water-resistant and non-porous resin. 125 
Qualitative analyses with endoscopy and CT-scans were performed on the replica to assess the 126 
anatomical reproducibility (Durand et al., 2011). As shown in Figure 1, this human upper airway 127 
replica was placed in an exposition chamber allowing aerosol dispersion between 0.6 and 0.9 128 
mL.min-1 of the calibrated suspensions. This replica was linked to a pump (model 420-2902 – 230 129 
VAC, 50 Hz, 0.6 Amp, 1 PH, 0.02 HP, Thermo Scientific) to inhale the aerosol suspended in the 130 
exposition chamber. The thoracic region (TR) was simulated by a filter holder (filter kit and filter 131 
pad, PARI, PulmoMed) with a polycarbonate membrane (Nuclepore™ track-etched membrane 132 
filter, Whatman, GE Healthcare) that allowed optimal bacterial recovery. To avoid any bacterial 133 
contamination of the pump, a HEPA filter (Pall filter BB50TE, Pall Medical) was placed after the 134 
thoracic filters. Five millilitres and 10 mL of the Legionella calibrated suspensions were nebulized 135 
in the respiratory model by a vibrating-mesh nebulizer or jet nebulizer, respectively. For safety 136 
reasons, the experimental setup was placed in a glove box (815-PGB “La petite glove box”, Fisher 137 
Scientific). For quantification of the percentage of droplets reaching the filter holder, the 138 
polycarbonate membrane was weighed (1 g = 1 mL of water) before and after nebulization. After 139 
nebulization, the polycarbonate membrane was placed in 5 mL of physiological sterile water. 140 
After a 30 sec sonication (Bransonic 32 sonicator bath, Branson Instruments, Danbury, CT USA), 141 
the membrane was scraped using an automatic pipette tip. One millilitre was plated twice on 142 
adapted culture media to count the viable and culturable (VC) Legionella. One millilitre was 143 
placed in a tube for DNA extraction and qPCR analysis. One millilitre was placed in a flow 144 
cytometric tube for flow cytometry assays (FCAs). 145 
 146 
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 147 
Figure 1 Human-like shower experimental setup inside a glove box. This experimental setup 148 
mimics the dispersion and collection of Legionella aerosols under the breathing conditions of an 149 
adult male. TR: Thoracic region mimicked by a polycarbonate membrane inside a filter holder. 150 
 151 
Legionella strain, culture and flow cytometry for the nebulization process 152 
L. pneumophila serogroup 1 strain expressing green fluorescent protein (Lp1 008-GFP) was used. 153 
The strain was stored at -80°C in Cryobank tubes (Mast Diagnostic, Amiens, France). After 154 
thawing, Lp1 008-GFP was plated onto BCYE agar (Buffered Charcoal Yeast Extract, SR0110 C, 155 
Oxoid, France) supplemented with chloramphenicol (Sigma Aldrich, France) at 8 mg/mL (for GFP 156 
plasmid selection) for 72 h at 37°C. The samples were then re-plated onto the same media and 157 
incubated at 37°C for another 3 days to obtain Legionella EPF cells (Robertson et al., 2014). A 158 
suspension with an optical density of 0.2 at 600 nm (Biomate TM3, Avantec) was then used to 159 
achieve a 20 mL calibrated suspension (CS) in sterile normal saline (0.9% NaCl) solution at a 160 
concentration between 2.0 x 106 and 2.0 x 107 CFU.mL-1. 161 
8 
The culturability (determination of the number of viable and culturable Legionella - VC) was 162 
assessed in duplicate by plating on BCYE agar, supplemented with chloramphenicol, 100 µL and 163 
500 µL of the suspension retrieved from the polycarbonate membrane. After incubation for 72 h 164 
at 37°C, all the BCYE plates were observed under UV at 366 nm to quantify the Legionella 165 
colonies (CFU) expressing GFP. 166 
The physiological states of the airborne Legionella collected in the thoracic region (TR) were 167 
quantified by flow cytometry assays (FCAs) as previously described (Allegra et al., 2016, 2008). 168 
Briefly, the FCAs profiles of the samples were obtained by using a combination of GFP green 169 
fluorescence (viable cells expressing GFP) and propidium iodide (PI) red fluorescence for cells 170 
with damaged membranes. Flow cytometric measurements were performed using a CyFlow 171 
Cube6 instrument (Sysmex Partec) equipped with an air-cooled argon laser (488-nm emission; 20 172 
mW). The green fluorescence emission from GFP was collected in the FL1 channel (500 to 560 173 
nm), and the red fluorescence from PI was collected in the FL3 channel (670 nm). A threshold 174 
was applied onto the FL1 channel to eliminate background signals. Analyses were performed at a 175 
low-flow-rate setting. The results were analysed with FCS Express software (De Novo Software). 176 
 177 
Quantification by qPCR 178 
The total number of bacteria in the shower water network and in bioaerosols was quantified 179 
using the 16S RNA gene as a target. Each reaction tube contained 5 µL of DNA extract, 2.5 µL of 180 
each primer at 10 pmol/µL (5’-AGG GTT GAT AGG TTA AGA GC-3’ and 5’-CCA ACA GCT AGT TGA 181 
CAT CG-3’) and 10 µL of the 2X Power SYBR® Green PCR Master Mix (Life Technologies). The 182 
standard curve was established using a mix of Escherichia coli, Pseudomonas aeruginosa, 183 
Staphylococcus aureus and the L. pneumophila sg1 strain isolated from water (strain collections 184 
of the teaching laboratory of Technical University Institute of Saint-Etienne). A suspension of an 185 
optical density of 0.2 at 600 nm (Biomate TM3, Avantec) was made for each bacterial strain. One 186 
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millilitre of each suspension was mixed and DNA was extracted from 1 mL of this latter 187 
suspension (Power Water DNA extraction kit - MoBio). 1:10 serial dilutions of this DNA were 188 
prepared and 5 µL of each dilution were used as template to generate the standard curve. 189 
Meanwhile, the total number of bacteria in CFUs was determined by culture. 190 
The number of Legionella during the nebulization process was determined using the GFP mut2 191 
sequence of the Lp1 008-GFP strain (template DNA 5 µL). The forward and reverse primers were 192 
5’-AGAGTGCCATGCCCGAAGG -3’ and 5’-AAGGACAGGGCCATCGCCAA-3’, respectively (2.5 µL of 193 
each primer at 10 pmol/µL). Ten microliters of the 2X Power SYBR® Green PCR Master Mix (Life 194 
Technologies) were used for each reaction. A standard curve was generated with Lp1 008-GFP 195 
suspensions ranging from 2.0x107 to 2.0x101 CFU.mL-1. Plasmid DNA extraction from all samples 196 
was performed with a NuCleoSpin Plasmid kit (Macherey-Nagel) following the manufacturer’s 197 
instructions. 198 
qPCR analyses were carried out on an ABI Prism 7500 automated system (Applied Biosystems), 199 
as follows: initial denaturation for 15 min and a two-step cycle consisting of 15 s denaturation, 1 200 
min annealing and elongation at 60 °C. At the end of each elongation step, the fluorescence of 201 
the incorporated SYBR green dye was measured. At the end of 45 cycles of amplification, a 202 
melting curve programme was incorporated to identify primer dimers or other non-specific 203 
amplifications. Each sample was run in duplicate. The results were analysed using Sequence 204 
Detection Software version 1.4 (ABI 7500 System Software, Applied Biosystems). 205 
The results were expressed in genomic units (GU). When a comparison with cell counts was 206 
necessary, and to a better understanding, data was expressed in colonies forming units (CFUs) 207 
according to the standard curves. 208 
 209 
Biological characterization and aerodynamic features of aerosols generated by a jet nebulizer 210 
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We compared two different technologies used for bioaerosol generation: a vibrating-mesh 211 
nebulization system and a jet nebulizer. A vibrating-mesh nebulizer, a medical device (eRapid® 212 
Nebulizer System by PARI, Cystic Fibrosis Services) used to aerosolize the bacterial suspensions, 213 
was linked to a small compressor and delivers aerosols with a vibrating membrane technology. 214 
The jet nebulizer used was a Bio-Aerosol Nebulizing Generator (BANG, VitroCell®). This system is 215 
specifically designed for the generation of aqueous aerosols at a low air flow rate. Based on the 216 
aerosolization principle of the Collison nebulizer, the design of the BANG has been modified to 217 
minimize foaming of protein solutions and thus increase the viability of microorganisms in 218 
bioaerosols while maximizing aerosol output. 219 
The aerodynamic features of the jet nebulizer were determined as previously described (Allegra 220 
et al., 2016). Briefly, the airborne particle size distribution was assessed using a 12-stage cascade 221 
low pressure impactor (DLPI, Dekati, Finland). The size classification in DLPI was made from 30 222 
nm up to 10 µm with evenly distributed impactor stages. Each stage of the cascade impactor was 223 
covered with a polycarbonate membrane (Nuclepore™ track-etched membrane filters, 224 
Whatman, GE Healthcare) to collect Legionella aerosols. After nebulization, each membrane was 225 
placed in 5 mL of physiological sterile water. After a 30 sec sonication (Bransonic 32 sonicator 226 
bath, Branson Instruments, Danbury, CT, USA), the bacterial suspensions of each stage were 227 
analysed by GFP mut2 qPCR. The mass median aerodynamic diameter (MMAD) was calculated. 228 
The MMAD was defined as the median of the distribution of airborne particle mass with respect 229 
to the aerodynamic diameter. 230 
 231 
Results 232 
Quantification of the exposure to airborne bacteria during one minute in the shower as a 233 
reference 234 
11 
The technical features of the “real” shower are presented in Figure 2. As determined by qPCR, 235 
the total bacteria concentration in the water network was 3.3 ± 1.0 x 104 bacteria.L-1. Assuming 236 
that the aerosols are evenly distributed in the shower space, when extrapolating the numbers, 237 
we found that the mean number of bacteria collected per minute by the Coriolis® Delta air 238 
sampler was 8.6 ± 3.2 x 102. As the shower cubicle has a volume of 1.125 m3, the Coriolis® 239 
system (300 L.min-1) can collect 26.7% of the air per minute. The actual number of bacteria per 240 
minute in the shower cubicle was therefore 3.2 x 103, and the number of aerosolized bacteria in 241 
the shower cubicle was 2.9 x 103 bacteria.m3. The volume of air inhaled by an adult male at rest 242 
is 7.5 x 10-3 m3.min-1. Therefore, in the specific case studied, we can estimate that a human male 243 
at rest inhales approximately 22 bacteria per minute during a shower. 244 
 245 
 246 
Figure 2 Summary of the experimental and calculated data from shower analysis. The number of 247 
inhaled bacteria was calculated based on results obtained by qPCR under the breathing 248 
conditions of an adult male and extrapolated from the characteristics of the shower and Coriolis 249 
air sampler. The results are from 3 independent experiments. 250 
 251 
Legionella exposure quantification in the experimental setup 252 
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The amount of Legionella reaching the thoracic region was assessed by culture, FCA and qPCR. 253 
The number of viable and culturable Legionella (VC) was determined by culture. FCA allowed the 254 
quantification of viable and potentially pathogen bacteria (VC and VBNC), and qPCR was used to 255 
quantify the total DNA from VC, VBNC and dead cells (DCs). 256 
Inside the experimental setup used with the vibrating-mesh nebulizer or with the jet nebulizer to 257 
generate bioaerosols, the volume per minute of calibrated suspension dispersed around the 258 
human 3D replica of the upper airways was 1.00 ± 0.25 mL.min-1 and 0.16 ± 0.06 mL.min-1, 259 
respectively. As determined by qPCR, only 2.0 ± 0.3% of the total Legionella DNA dispersed from 260 
the jet nebulizer could reach the thoracic region compared to 11 ± 9.6% from the vibrating-mesh 261 
nebulizer. In the experiments with the jet nebulizer, no significant values were obtained in the 262 
culture and FCA experiments. The amount of culturable and viable bacteria that could be 263 
detected was below the detection limits of the culture and FCA methods. Table 1 shows all the 264 
results obtained with the vibrating-mesh nebulizer. 265 
qPCR was used to quantify all Legionella physiological states, including dead cells. We found that 266 
11 ± 9.6% of the total aerosolized Legionella DNA could reach the thoracic region. From the 267 
culture results, only 0.5 ± 0.7% of the culturable aerosolized Legionella was detected in the 268 
thoracic region. As expected, the culture method underestimates the real Legionella risk. Finally, 269 
with the FCA results, we observed that through the human anatomical model, the thoracic 270 
region was exposed to 4.3 ± 4.0% of the viable (VC + VBNC) aerosolized Legionella. 271 
 272 
Table 1 Quantifications of aerosols generated by a vibrating-mesh nebulizer and reaching the TR 273 
of the shower-like experimental setup. Weighing experiments show the quantity of droplets 274 
reaching the TR. CS: calibrated suspension; TR: thoracic region; VC: viable and culturable 275 
bacteria; VBNC: viable but not culturable bacteria; DC: dead cells; CFU: colony forming unit; GU: 276 
genomic unit; SD: standard deviation. The results are from 20 independent experiments. 277 
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 278 
   
Mean SD Min Max 
  
Time of nebulization (min) 3.9 0.8 2.4 5.4 
  
Volume of aerosolized CS (mL) 3.7 0.3 3.1 4.2 
  
% of water reaching TR 21 5.3 14 30 
Culture 
Amount of aerosolized VC (CFU) 9.3 x 10
7
 2.5 x 10
7
 5.3 x 10
7
 1.4 x 10
8
 
Amount of VC on membrane (CFU) 5.1 x 10
5
 7.7 x 10
5
 0.0 2.6 x 10
6
 
% of VC reaching TR 0.5 0.7 0.0 1.9 
FCA 
Viable bacteria 
(VC+VBNC) 
Amount of aerosolized Viable bacteria 
(CFU) 3.7 x 10
7
 3.1 x 10
7
 7.5 x 10
5
 1.0 x 10
8
 
Amount of Viable bacteria on 
membrane (CFU) 2.1 x 10
6
 3.4 x 10
6
 1.0 x 10
4
 1.3 x 10
7
 
% of Viable reaching TR 4.3 4.0 0.9 17 
qPCR 
Total bacteria 
(VC+VBNC+DC) 
Amount of aerosolized Total bacteria 
(GU) 2.0 x 10
7
 2.0 x 10
7
 1.1 x 10
6
 7.1 x 10
7
 
Amount of Total bacteria on membrane 
(GU) 1.1 x 10
6
 9.0 x 10
5
 3.4 x 10
5
 2.6 x 10
6
 
% of Total reaching TR 11 9.6 2 34 
 279 
Comparison of the exposure to bacteria 280 
To determine if the shower-like experimental setup satisfactorily mimics a bioaerosol shower 281 
exposure, we compared the number of inhaled bacteria for a one-minute shower event (Table 282 
2). As we used the “real” shower as a reference, the number of bacteria in the nebulizer’s 283 
reservoir (5 mL or 10 mL for the vibrating-mesh and jet nebulizer, respectively) was fixed at 3.3 x 284 
104 bacteria. The results in Table 2 indicate that the experimental setup developed 285 
underestimates by 2 times (if the jet nebulizer is used) or overestimates by 43 times (if the 286 
vibrating-mesh nebulizer is used) the emitted dose of total (VC, VBNC and DC) airborne bacteria. 287 
 288 
Table 2 Comparison of bacterial exposure between a “real” shower event and a one-minute 289 
shower-like experimental setup. VC: viable and culturable bacteria; viable (VC + VBNC); TR: 290 
thoracic region. See Supplementary data for equations and calculations used. 291 
 292 
 
Shower as a reference (SS) Experimental setup (SE) 
14 
Vibrating-mesh nebulizer Jet nebulizer 
 
Total VC Viable Total Total 
Exposition chamber (dimensions, 
volumes) 0.75 m x 0.75 m x 2 m =1.125 m
3
 0.232 m x 0.172 m x 0.092 m = 3.7 x 10
-3 m
3
 
Water flowrate of the source (L.min-1) 11.5 1 x 10
-3
 1.6 x 10
-4
 
CW (bacteria.L
-1
): source water 
concentration 
3.3 x 10
4
 
CA (bacteria.m
-3
): bacterial air 
concentration  
2.9 x 10
3
 8.9 x 10
3
 1.4 x 10
3
 
Flowrate of bacteria coming from the 
source (bacteria.min
-1
) 
3.8 x 10
5
 33 5 
Inhaled bacteria (in % of bacteria 
coming from the source) 
0.006 0.5 4.3 11 2 
Number of inhaled bacteria 
(bacteria.min
-1
) 
22 41 3.8 x 10
2
 9.4 x 10
2
 11 
Ratio: SE / SS for inhaled bacteria or 
bacteria reaching TR 
1 2 17 43 0.5 
 293 
Features of the aerosols generated by nebulization 294 
The aerodynamic features of the aerosols generated by the jet nebulizer were compared to 295 
those of the vibrating-mesh nebulizer that were previously determined (Allegra et al., 2016). 296 
Figure 3 shows the repartition of Legionella depending on the aerosol size. Table 3 presents the 297 
proportions of viable and potentially pathogenic airborne bacteria. Both nebulizer profiles were 298 
examined for the aerosol fraction that could reach the thoracic region (0.26 µm to 2.4 µm). 299 
From the literature and our previously published data with the vibrating-mesh nebulizer (Allegra 300 
et al., 2016; Perinel et al., 2018; Pourchez et al., 2017), we confirmed that Legionella EPF cells 301 
(Robertson et al., 2014) are approximately 1–2 µm long and 0.3–0.9 µm wide. Several studies 302 
have shown that bioaerosol droplets of more than 2.5 μm in diameter cannot reach the 303 
pulmonary alveoli (Leclerc et al., 2015; Pourchez et al., 2013; Schlesinger, 1989). In this study, 304 
depending on the cut-off diameters of the cascade impactor (DLPI), we defined the fraction of 305 
viable Legionella bioaerosol diameters ranging from 0.26 µm to 2.4 μm as the fraction that can 306 
reach the pulmonary alveoli and cause infection. 307 
15 
First, we obtained similar results (by qPCR) between the percentage of bacteria reaching the 308 
thoracic region (Table 1) and the percentage of bacteria collected in the DLPI (Table 3): 2.0 ± 309 
0.3% compared to 2.4 ± 0.1% for the jet nebulizer and 11 ± 9.6% compared to 12.8 ± 1.1% for the 310 
vibrating-mesh nebulizer (p>0,5 for the two tests). 311 
Second, the results obtained with the jet nebulizer confirmed that (i) VC cells were detected with 312 
the 262 nm cut-off diameter and (ii) the Legionella physiological states were not modified by the 313 
nebulization process or by its transportation on the 12-stage DLPI (same % of VC, VBNC and DC 314 
were obtained by FCA – data not shown). The jet nebulizer generated smaller airborne droplets 315 
than the vibrating-mesh nebulizer (MMAD of 1.2 ± 0.4 µm for the jet nebulizer versus 3.4 ± 0.4 316 
µm for the vibrating-mesh nebulizer), but the same proportions of viable and potentially 317 
pathogen airborne bacteria (42 ± 3.2% and 48 ± 5%, respectively) can reach the deep lung. 318 
 319 
 320 
16 
Figure 3 Cumulative distribution of Legionella aerosols generated by the 2 types of nebulizers. 321 
GU: genomic units. Results from 10 and 30 independent experiments for the jet nebulizer and 322 
vibrating-mesh nebulizer, respectively. 323 
 324 
Table 3 Characteristics of Legionella aerosols generated by the 2 types of nebulizers. GU: 325 
genomic units. MMAD: mass median aerodynamic diameter. DLPI: low pressure cascade 326 
impactor. Results from 10 and 30 independent experiments for the jet nebulizer and vibrating-327 
mesh nebulizer, respectively. 328 
 329 
Aerosols containing Legionella Vibrating-mesh nebulizer Jet nebulizer 
MMAD for 50% of GU 3.4 ± 0.4 µm 1.2 ± 0.4 µm 
Percentage of aerosols dispersed 
in DLPI from nebulizer reservoir 
12.8 ± 1.1%  2.4 ± 0.1%  
Total 12-stage DLPI 100%  100% 
Trachea (2.4-10µm) 44.4 ± 4.6% 34 ± 4.3% 
The pulmonary region  
  
Viable bacteria (0.26-2.4µm) 48.3 ± 5% 42.1 ± 3.2% 
Cellular fragments (0.03-0.26µm) 7.3 ± 4.5% 23.9 ± 1.1% 
 330 
Discussion 331 
QMRA provides a very useful methodology to manage the risk of infections by foodborne or 332 
some waterborne pathogens with simple cases of contamination. Legionella is currently a well-333 
documented human waterborne pathogen, but as shown by Bentham and Whiley (Bentham and 334 
Whiley, 2018; Whiley et al., 2014), persistent and indeterminable uncertainties remain regarding 335 
Legionella epidemiology, frequency of exposure, aerosol characterization (quantity, size, content 336 
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of Legionella), strain infectivity, infectious dose and detection methods. No risk acceptance 337 
threshold is currently validated. However, in the context of global change and diminishing water 338 
resources, the need to use various water sources will lead to a need for the development and 339 
use of LCA (life cycle assessment) and QMRA methodologies (Harder et al., 2017; National 340 
Academies of Sciences and Medicine, 2019). To optimize these risk assessment and prevention 341 
methods, our studies using different detection methods of Legionella (Allegra et al., 2008; 342 
Allegra et al., 2011; Allegra et al., 2011), aimed to characterize the aerosol generation (Allegra et 343 
al., 2016; Pourchez et al., 2017) and the inhaled aerosols that can reach pulmonary cells (Perinel 344 
et al., 2018). The experimental setup developed in this study proposes a model as close as 345 
possible to the human anatomy and physiology, respecting the 3R rule (Replacement, Reduction 346 
and Refinement) and consequently does not raise ethical issues. The model is easy to handle and 347 
has physiological similarities to human ventilation. Some factors, such as the nasal and bronchial 348 
mucosa, the ciliated cells, the secretion of mucus/surfactant and the body temperature, could 349 
not be taken into account in the model. Nevertheless, depending on the use of the vibrating-350 
mesh or jet nebulizer, we can adapt the experimental configuration to mimic the exposure to 351 
Legionella aerosols generated by different shower-like systems. 352 
 Bioaerosol generation from shower-like systems 353 
Regarding aerosol dispersion (quantity, size), the discrepancy between the results from the 354 
different studies is due to the different methods and apparatuses used to measure the air 355 
bacteria concentration and to numerous other factors, such as ambient humidity, type of shower 356 
stall, design of the showerhead, water temperature, piping materials, human occupants or 357 
bacterial communities and biofilm development. Several publications (Chattopadhyay et al., 358 
2017; Cowen and Ollison, 2006; Estrada-Perez et al., 2018; O’Toole et al., 2009; Perkins et al., 359 
2009; Zhou et al., 2007) have shown that (i) a shower with the low-flow showerhead generates a 360 
significantly higher number of aerosols than a high-flow shower. (ii) A hot shower (approximately 361 
18 
40°C) increases the rate of evaporation; therefore, the number of small particles within the 362 
breathable range is increased, and the culturability of cells is decreased with the turn off to the 363 
VBNC state, as shown for Pseudomonas and Legionella. (iii) The number of bioaerosols 364 
generated during a shower is not only dependent on the concentration of bacteria in the water 365 
network. As an example, Zhou et al. (Zhou et al., 2007) demonstrated that the particle size 366 
distribution of shower aerosols was only mildly affected by the water flow rate in the case of hot 367 
water experiments showing droplet size in the 5 µm range. However, for cold water, the particle 368 
distribution varied significantly with the flow rate, and the droplets generated were smaller, 369 
approximately 2 µm. The two nebulization technologies used in this study generated similar 370 
proportions of viable and potentially pathogenic airborne Legionella that could reach the lungs. 371 
In addition, the droplet size generated by the vibrating-mesh nebulizer (MMAD of 3.4 µm) 372 
appeared to be representative of a shower using lukewarm water. However, the jet nebulizer, 373 
which generates smaller airborne droplets (MMAD of 1.2 µm) seems to be representative of a 374 
shower using cold water. Moreover, these nebulizers could also mimic the bioaerosol 375 
characteristics from new sources of LD, such as a spa (Moore et al., 2015) or bioaerosols 376 
generated by wastewater treatment tanks (Wang et al., 2019). 377 
Concerning aerosol content, we can identify 4 modes of transportation during the aerosolization 378 
of Legionella (Allegra et al., 2016): cellular fragments of Legionella (entrapped or not) in droplets 379 
(28–262 nm), airborne bacteria not entrapped in droplets and oriented by the air flow direction 380 
during the respiration process (0.262–0.949 μm), airborne bacteria (entrapped or not) in 381 
droplets or in amoeba vacuoles (0.949–1.6 μm), and airborne bacteria packaged in droplets or in 382 
amoebae vacuoles (1.6–9.92 μm). VC Legionella was also detected as early as the 262 nm cut-off 383 
diameter of DLPI, confirming that Legionella bacilli have a size of approximately 1–2 μm long and 384 
0.3–0.9 μm wide and can reach the deep lung. In the context of this study, we demonstrated a 385 
new data that the Legionella physiological states were not modified by the nebulization process 386 
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or by its transportation through the 12-stage DLPI or the anatomical model. Thermally or 387 
chlorine-induced VBNC Legionella pneumophila may still infect amoebae and pulmonary cells 388 
after resuscitation on amoebae (Cervero-Aragó et al., 2019; Epalle et al., 2015; Mustapha et al., 389 
2015). VBNC cell concentrations in the water network must be included in the QMRA models. 390 
 Exposure and dose-response modelling 391 
There is currently no consensus on a threshold for the acceptability of microbiological risk. The 392 
acceptable risk of infection set by the WHO for waterborne pathogens is less than one infection 393 
per 10000 persons per year and stipulates that risk assessment be undertaken for waterborne 394 
pathogens to demonstrate microbiologically safe water (World Health Organization, 2016). The 395 
calculation and the expression of the result of the risk differ according to the authors (Azuma et 396 
al., 2013; Bouwknegt et al., 2013; Kerry A. Hamilton et al., 2018; Schoen and Ashbolt, 2011; 397 
Sharaby et al., 2019). Indeed, the annual risk estimation varies significantly between the scenario 398 
analyses: the dose response model chosen (clinical severity, incidence of LD or/and Pontiac 399 
fever, during or after an outbreak, etc.), the population at risk (residential or occupational), the 400 
detection method (culture-based, EMA-qPCR, or qPCR), the meteorological conditions, etc. 401 
The exposure assessment (duration, frequency) consists of determining the inhaled quantity of 402 
potentially pathogenic Legionella. However, the amount of inhaled air will depend on the activity 403 
of the subject and the exposure scenario. It is therefore easier to evaluate and model the risk 404 
associated with the generation of aerosols by shower-like systems rather than cooling towers. 405 
Our study shows similarities and complementarities with 2 other recent studies from 406 
Chattopadhyay et al. (Chattopadhyay et al., 2017) and Estrada-Perez et al. (Estrada-Perez et al., 407 
2018) in term of aerosol samplers, Gram-negative bacillus targets, and detection methods. Table 408 
4 shows that the concentrations of Legionella aerosols generated by the vibrating-mesh 409 
nebulizer (8.9 x 103 CFU.m3) or by the jet nebulizer (1.4 x 103 CFU.m3.min-1) in our experimental 410 
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setup effectively mimic an emitted dose of shower bacteria. The air bacteria concentrations 411 
measured in these three studies were of the same order of magnitude. 412 
 413 
Table 4 Comparison of the experimental conditions and results between our study and 2 recent, 414 
close and complementary studies. 415 
 416 
Studies using animal models or manikins calculate the dose of inhaled Legionella from 417 
mathematical models. Here, bioaerosols were inhaled by a well-validated 3D replica of the upper 418 
airways (Le Guellec et al., 2014; Pourchez et al., 2017). A respiratory pump was used, to fit the 419 
breathing parameters corresponding to adult male physiology at rest: a breathing rate of 15 420 
breaths per minute and a tidal volume of 500 mL. The number of viable bacteria reaching the 421 
thoracic region represents the dose of inhaled Legionella that can result in LD. As observed in 422 
Table 1, 4.3 ± 4.0% of the viable (VC + VBNC) Legionella aerosolized during the experimentation 423 
(experimental setup combined with the vibrating-mesh nebulizer) reached the thoracic region. In 424 
the context of the shower used as a reference (water network contaminated by 3.3 x 104 425 
Legionella.L-1), 22 viable and potentially pathogenic Legionella may reach the pulmonary region 426 
after a one-minute shower. Depending on the exposure scenario, we now have several 427 
experimental setups to mimic a large range of shower systems, by adjusting the concentration of 428 
21 
bacteria in the water network, the nebulizers settings and the time of experimentation, to 429 
provide robust data to scientific experts for QMRA development. 430 
 431 
Conclusion 432 
 Viable and cultivable aerosolized Legionella bacilli were detected as early as the 262 nm 433 
cut-off diameter of DLPI, confirming that Legionella bacilli are approximately 1–2 μm 434 
long and 0.3–0.9 μm wide and can reach the deep lung. 435 
 The Legionella physiological states were not modified by the nebulization process or by 436 
its transportation through the 12-stage DLPI or the anatomical model. 437 
 After a one-minute shower (used as a reference in this study), contaminated by 3 x 104 438 
Legionella cells/L, 22 viable and potentially pathogenic Legionella cells may reach the 439 
pulmonary region of an adult male. 440 
 The characteristics of the 2 nebulizers can allow the adaptation of our experimental 441 
setup to analyse the exposure to different shower-like systems. 442 
 This original experimental setup will provide data to accurately quantify the Legionella 443 
risk exposure and the dose-response in the context of a Legionella infection from a water 444 
network to deposition in the lung. 445 
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